#Immunoassay Market Share

[globalgrowthinsights]

Future Predictions and Current Dynamics of the Lateral Flow Immunoassay Based Rapid Tests Market 2024 | Global Growth Insights

""Lateral Flow Immunoassay Based Rapid Tests Market""provides in-depth analysis on the market status of Lateral Flow Immunoassay Based Rapid Tests Market, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most recent developments worldwide. The report also computes market size, Price, Revenue, Cost Structure, Gross Margin, Lateral Flow Immunoassay Based Rapid Tests Market Sales, and Market Share, Forecast and Growth Rate. The report helps to determine the revenue generated by the sale of this report and technologies across various application segments.

It is projected that between 2024 and 2032, The Global Lateral Flow Immunoassay Based Rapid Tests Market would grow at a significant rate. In 2023, the market is likely to grow rapidly and over the estimated horizon due to the growing adoption of strategies by major players. This research provides a detailed analysis of the market size, characteristics, and growth of the Lateral Flow Immunoassay Based Rapid Tests Market industry from 2024 to 2032. It is segmented based on the product type, downstream application, and consumption area of Lateral Flow Immunoassay Based Rapid Tests Market. Along with introducing industry participants from a value chain viewpoint, the research also examines the top businesses.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Lateral Flow Immunoassay Based Rapid Tests Market in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

For more Click Here : https://www.globalgrowthinsights.com

Key Attentions of Lateral Flow Immunoassay Based Rapid Tests Market Report:

The report offers a comprehensive and broad perspective on the global Lateral Flow Immunoassay Based Rapid Tests Market.

The market statistics represented in different Lateral Flow Immunoassay Based Rapid Tests Market segments offers complete industry picture.

Market growth drivers, challenges affecting the development of Lateral Flow Immunoassay Based Rapid Tests Market are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of Lateral Flow Immunoassay Based Rapid Tests Market.

Major stakeholders, key companies Lateral Flow Immunoassay Based Rapid Tests Market, investment feasibility and new market entrants study is offered.

Development scope of Lateral Flow Immunoassay Based Rapid Tests Market in each market segment is covered in this report. The macro and micro-economic factors affecting the Lateral Flow Immunoassay Based Rapid Tests Market

Advancement is elaborated in this report. The upstream and downstream components of Lateral Flow Immunoassay Based Rapid Tests Market and a comprehensive value chain are explained.

Browse More Details On This Report at:-  https://www.globalgrowthinsights.com/market-reports/lateral-flow-immunoassay-based-rapid-tests-market-101353

Global Growth Insights

Phone:

  US: +1 (888) 690-5999    UK: +44 8083 023308

Email: sales@globalgrowthinsights.com

[businessindustry]

Chemiluminescence Immunoassay (CLIA) Market Application, Growth 2024-2032

The Reports and Insights, a leading market research company, has recently releases report titled “Chemiluminescence Immunoassay (CLIA) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Chemiluminescence Immunoassay (CLIA) Market Forecast share, size, trends, and growth. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Chemiluminescence Immunoassay (CLIA) Market?

As per Reports and Insights Analysis, the chemiluminescence immunoassay (CLIA) market is expected to grow at a CAGR of 7.8% during the forecast period of 2024 to 2032.

What are Chemiluminescence Immunoassay (CLIA)?

Chemiluminescence immunoassay (CLIA) is a precise diagnostic method used to detect and measure specific substances, such as proteins, hormones, or antibodies, in a sample. It employs chemiluminescent labels attached to antibodies or antigens that emit light when they bind to their target analytes. This emitted light is quantified using a luminometer, providing a measurement proportional to the concentration of the target substance. CLIA is renowned for its high sensitivity and specificity, making it a valuable tool in clinical diagnostics, research, and various applications in medical and biochemical analysis.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/1671

What are the growth prospects and trends in the Chemiluminescence Immunoassay (CLIA) industry?

The chemiluminescence immunoassay (CLIA) market growth is driven by various factors and trends. The chemiluminescence immunoassay (CLIA) market is experiencing significant growth due to its widespread application in clinical diagnostics and research for accurate detection and quantification of biomarkers. This expansion is fueled by the increasing demand for precise diagnostic tools, advancements in assay technology, and the rising prevalence of chronic diseases. Ongoing innovations in CLIA technology, including the development of new reagents and platforms, are also driving market growth. Leading companies are heavily investing in research and development to improve assay performance and address the evolving needs of the healthcare and research sectors, thereby boosting the overall CLIA market. Hence, all these factors contribute to chemiluminescence immunoassay (CLIA) market growth. 

What is included in market segmentation?

The report has segmented the market into the following categories:

By Product Type:

Analyzers

Reagents & Consumables

By Analyzer Type:

Benchtop Analyzers

Floor-standing Analyzers

By Application:

Infectious Diseases

Oncology

Cardiology

Autoimmune Diseases

Others

By End-Use:

Hospitals & Diagnostic Laboratories

Research & Academic Institutes

Pharmaceutical & Biotechnology Companies

Contract Research Organizations (CROs)

Segmentation By Region:

North America:

United States

Canada

Asia Pacific:

China

India

Japan

Australia & New Zealand

Association of Southeast Asian Nations (ASEAN)

Rest of Asia Pacific

Europe:

Germany

The U.K.

France

Spain

Italy

Russia

Poland

BENELUX (Belgium, the Netherlands, Luxembourg)

NORDIC (Norway, Sweden, Finland, Denmark)

Rest of Europ

Latin America:

Brazil

Mexico

Argentina

Rest of Latin America

The Middle East & Africa:

Saudi Arabia

United Arab Emirates

South Africa

Egypt

Israel

Rest of MEA (Middle East & Africa)

Who are the key players operating in the industry?

The report covers the major market players including:

Roche Diagnostics

Siemens Healthineers

Abbott Laboratories

Beckman Coulter (a subsidiary of Danaher Corporation)

Ortho Clinical Diagnostics

bioMérieux SA

DiaSorin S.p.A.

Sysmex Corporation

Thermo Fisher Scientific Inc.

Mindray Bio-Medical Electronics Co., Ltd.

Randox Laboratories Ltd.

Snibe Diagnostic

View Full Report: https://www.reportsandinsights.com/report/Chemiluminescence Immunoassay (CLIA)-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: sales@reportsandinsights.com Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

[mitalipingale]

The Immunoassay Analyzers Market is expected to reach US$ 142.83 billion by 2031 at a CAGR of 15.45%.

[delicatemagazinedreamer]

Chemiluminescence Immunoassay Market Is Estimated To Witness High Growth Owing To Increasing Demand for Accurate and Rapid Diagnostic Solutions

The global Chemiluminescence Immunoassay Market is estimated to be valued at US$ 6.01 Bn in 2021 and is expected to exhibit a CAGR of 8.0% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Chemiluminescence immunoassay (CLIA) is a widely used diagnostic technique that combines the principles of chemiluminescence and immunoassay to detect the presence of specific analytes in patient samples. This technique offers several advantages such as high sensitivity, specificity, and rapid results, making it a preferred choice in clinical laboratories and research settings. The increasing prevalence of infectious diseases, cancer, and chronic conditions, along with the need for accurate and rapid diagnostic solutions, is driving the demand for chemiluminescence immunoassay products. B) Market Key Trends: The key trend driving the growth of the chemiluminescence immunoassay market is the increasing adoption of automated platforms and systems. Automated chemiluminescence immunoassay systems offer several advantages such as reduced turnaround time, increased throughput, and improved accuracy compared to manual testing methods. These systems also enable simultaneous testing of multiple analytes, reducing the overall cost and time spent on sample processing. For example, Beckman Coulter Inc. offers the Access 2 Immunoassay System, which is a fully automated platform for chemiluminescence immunoassay testing. C) PEST Analysis: Political: The chemiluminescence immunoassay market is influenced by government regulations and policies related to the approval and reimbursement of diagnostic tests. Stringent regulatory requirements for assay validation and quality control drive manufacturers to adhere to strict standards. Economic: The growing healthcare expenditure and increasing investments in research and development activities in the healthcare sector are driving the growth of the chemiluminescence immunoassay market. The market is also influenced by factors such as healthcare infrastructure, insurance coverage, and affordability of diagnostic tests. D) Key Takeaways: - The global Chemiluminescence Immunoassay Market is expected to witness high growth, exhibiting a CAGR of 8.0% over the forecast period. This growth is primarily driven by the increasing demand for accurate and rapid diagnostic solutions. - North America is expected to dominate the chemiluminescence immunoassay market due to factors such as well-established healthcare infrastructure, high healthcare expenditure, and strong research and development activities in the region. - Key players operating in the global chemiluminescence immunoassay market include DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Tosoh Corporation, and Ortho Clinical Diagnostics. In conclusion, the global chemiluminescence immunoassay market is poised for significant growth in the coming years. The increasing demand for accurate and rapid diagnostic solutions, coupled with advancements in technology, is driving the adoption of chemiluminescence immunoassay products. Automated platforms and systems are emerging as a key trend in the market, offering improved efficiency and accuracy in diagnostic testing. North America is expected to dominate the market, given its well-established healthcare infrastructure and strong research and development activities. Key players in the market are focused on innovations and collaborations to gain a competitive edge in this growing market.

[stickyleadybloger]

https://midiario.com.mx/read-blog/16237

Immunoassay Analyzers Market Share, Development Status, Competition Analysis, Type and Application 2027

[kathansky]

Drug Screening Market: Competitive Insights and Precise Outlook | 2024-2031

Drug Screening Market Overview: A lot of factors, such as geographic growth, segmentation, and market size by value and volume, are taken into account in the SkyQuest Technology Group research to provide a full and accurate analysis of the global Drug Screening market. This outstanding research study was created specifically to provide the most latest data on significant aspects of the global Drug Screening Industry. Numerous market estimates are provided in the analysis, including those for market size, output, revenue, consumption, CAGR, gross margin, price, and other critical factors. The best primary and secondary research methods and tools on the Drug Screening market were used to build it. Numerous research studies are included in it, including ones on pricing analysis, production and consumption analysis, company profile, and manufacturing cost analysis.

Global Drug Screening Market size was valued at USD 8.9 billion in 2022 and is poised to grow from USD 10.37 billion in 2023 to USD 35.18 billion by 2031, growing at a CAGR of 16.5% during the forecast period (2024-2031). The competitive environment is a crucial element that every key factor needs to be aware of. The study explains the market's competitive landscape so that readers may gauge the degree of both domestic and global rivalry. Additionally, market researchers have provided summaries of each significant firm in the global Drug Screening industry, taking into consideration crucial elements including operational areas, production, and product portfolio. When analyzing the organizations in the study, significant factors including business size, market share, market growth, revenue, production volume, and profitability are also taken into account. The study report uses both qualitative and quantitative data to offer a thorough view of the market. It examines and forecasts the global market in a number of critical industries. The research provides a thorough overview of the industry by segmenting the Drug Screening market into groups based on application, end-user, and location. A thorough research of each market segment was conducted, taking into consideration current and upcoming market trends.

Chance to get a free sample @ https://www.skyquestt.com/sample-request/drug-screening-market  Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Drug Screening Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

Product & Service

Drug Screening Services [Laboratory Testing Services, On-site Testing Services], Drug Screening Products [Analytical Instruments (By Type {Breathalyzers “Fuel-cell Breathalyzers, Semiconductor Breathalyzers, Other Breathalyzers”, Immunoassay analyzers, Chromatography instruments}, By Modality {Hand-held drug screening products, Benchtop drug screening products}, Rapid Testing Devices (Urine testing devices {Drug testing cups, Dip cards, Drug testing cassettes}, Oral fluid testing devices), Consumables {Assay kit, Sample collection devices, Calibrators and controls, Other consumables}]

Sample Type

Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples

Drug Type

Cannabis, Alcohol, Cocaine, Opioids, Amphetamine and Methamphetamine, Other Drugs

End User

Drug Testing Laboratories, Workplaces, Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, Other End Users

Get your Customized report @ https://www.skyquestt.com/speak-with-analyst/drug-screening-market 

Following are the players analyzed in the report:

Quest Diagnostics (US) 

Abbott (US) 

OraSure Technologies Inc. (US) 

Alfa Scientific Designs Inc. (US) 

Thermo Fisher Scientific, Inc. (US) 

Drägerwerk AG & Co. KGaA (Germany) 

Lifeloc Technologies, Inc. (US) 

MPD Inc. (US) 

Omega Laboratories, Inc. (US) 

Premier Biotech, Inc. (US) 

Psychemedics Corporation (US) 

F. Hoffmann-La Roche Ltd. (Switzerland) 

Shimadzu Corporation (Japan) 

Siemens Healthineers AG (Germany) 

American Bio Medica Corporation (US) 

ACM Global Laboratories (US) 

CareHealth America Corp. (US) 

Clinical Reference Laboratory, Inc. (US) 

Intoximeters (US) 

Sciteck, Inc. (US) 

AccuSourceHR, Inc. (US) 

Cordant Health Solutions (US) 

Intoxalock (US) 

Millennium Health (US) 

AdvaCare Pharma (US)

Motives for purchasing this report- - A full understanding of customer experiences, upcoming trends, and growth drivers may be obtained by market category analysis. -Drug Screening Market participants will be able to quickly decide on their course of action in order to achieve a competitive advantage thanks to the essential information provided in this area. The factors affecting the sales prospect are carefully examined by SkyQuest Technology Group across several important categories. - Analysing market categories can provide detailed insights into consumer experiences, upcoming trends, and growth-promoting factors. A thorough analysis of market manufacturing trends is a crucial component of the study. -These observations offer crucial information on the ways in which market participants are reacting to the most recent developments that are oversaturating the market. -An in-depth analysis of the numerous organic

Buy your full Market Report now: https://www.skyquestt.com/buy-now/drug-screening-market  FAQs:

1. What are the main vendors' points of strength and weakness?

2. What are the primary business plans of the leading important players for the near future?

3. What will the market size and growth rate be for Drug Screening in the upcoming year?

4. Which prevailing global trends are affecting the Drug Screening market shares of the leading regions? What effect does Covid19 have on the Industry right now?

[businessindustry]

Chemiluminescence Immunoassay (CLIA) Market Application, Growth 2024-2032

The Reports and Insights, a leading market research company, has recently releases report titled “Chemiluminescence Immunoassay (CLIA) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Chemiluminescence Immunoassay (CLIA) Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Chemiluminescence Immunoassay (CLIA) Market?

As per Reports and Insights Analysis, the chemiluminescence immunoassay (CLIA) market is expected to grow at a CAGR of 7.8% during the forecast period of 2024 to 2032.

What are Chemiluminescence Immunoassay (CLIA)?

Chemiluminescence immunoassay (CLIA) is a precise diagnostic method used to detect and measure specific substances, such as proteins, hormones, or antibodies, in a sample. It employs chemiluminescent labels attached to antibodies or antigens that emit light when they bind to their target analytes. This emitted light is quantified using a luminometer, providing a measurement proportional to the concentration of the target substance. CLIA is renowned for its high sensitivity and specificity, making it a valuable tool in clinical diagnostics, research, and various applications in medical and biochemical analysis.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/1671

What are the growth prospects and trends in the Chemiluminescence Immunoassay (CLIA) industry?

The chemiluminescence immunoassay (CLIA) market growth is driven by various factors and trends. The chemiluminescence immunoassay (CLIA) market is experiencing significant growth due to its widespread application in clinical diagnostics and research for accurate detection and quantification of biomarkers. This expansion is fueled by the increasing demand for precise diagnostic tools, advancements in assay technology, and the rising prevalence of chronic diseases. Ongoing innovations in CLIA technology, including the development of new reagents and platforms, are also driving market growth. Leading companies are heavily investing in research and development to improve assay performance and address the evolving needs of the healthcare and research sectors, thereby boosting the overall CLIA market. Hence, all these factors contribute to chemiluminescence immunoassay (CLIA) market growth. 

What is included in market segmentation?

The report has segmented the market into the following categories:

By Product Type:

Analyzers

Reagents & Consumables

By Analyzer Type:

Benchtop Analyzers

Floor-standing Analyzers

By Application:

Infectious Diseases

Oncology

Cardiology

Autoimmune Diseases

Others

By End-Use:

Hospitals & Diagnostic Laboratories

Research & Academic Institutes

Pharmaceutical & Biotechnology Companies

Contract Research Organizations (CROs)

Segmentation By Region:

North America:

United States

Canada

Asia Pacific:

China

India

Japan

Australia & New Zealand

Association of Southeast Asian Nations (ASEAN)

Rest of Asia Pacific

Europe:

Germany

The U.K.

France

Spain

Italy

Russia

Poland

BENELUX (Belgium, the Netherlands, Luxembourg)

NORDIC (Norway, Sweden, Finland, Denmark)

Rest of Europ

Latin America:

Brazil

Mexico

Argentina

Rest of Latin America

The Middle East & Africa:

Saudi Arabia

United Arab Emirates

South Africa

Egypt

Israel

Rest of MEA (Middle East & Africa)

Who are the key players operating in the industry?

The report covers the major market players including:

Roche Diagnostics

Siemens Healthineers

Abbott Laboratories

Beckman Coulter (a subsidiary of Danaher Corporation)

Ortho Clinical Diagnostics

bioMérieux SA

DiaSorin S.p.A.

Sysmex Corporation

Thermo Fisher Scientific Inc.

Mindray Bio-Medical Electronics Co., Ltd.

Randox Laboratories Ltd.

Snibe Diagnostic

View Full Report: https://www.reportsandinsights.com/report/Chemiluminescence Immunoassay (CLIA)-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: sales@reportsandinsights.com Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

[tamanna31]

Blood Screening Market 2023- Business Planning Research and Resources, Revenue, and Forecasts 2030

Blood Screening Market Size & Trends

The global blood screening market size was valued at USD 2.76 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% from 2023 to 2030. 

Blood screening is a process in which donated blood is screened for infectious diseases such as HBV, HCV, HIV1, and HIV2. The high growth of this market is attributed to rising blood donations, an increase in the incidence of infectious diseases, and government initiatives. According to World Health Organization (WHO), 118.54 million blood donations are collected yearly. In the U.S., 6.8 million individuals donate blood annually, and 13.6 million units of red blood cells and whole blood are collected annually.

Gather more insights about the market drivers, restrains and growth of the Blood Screening Market

The market is primarily driven by the rise in the rate of disorders such as HIV, diphtheria, measles and chronic diseases such as hemophilia, cancer, and other blood-related disorders. Blood-based diagnostics are used to diagnose a wide range of diseases, including infectious diseases, cancer, and cardiovascular diseases. Serology tests detect the presence of antibodies to a specific disease-causing organism. These tests diagnose various infectious diseases, including HIV, hepatitis B, and syphilis. Molecular tests detect the presence of DNA or RNA from a specific disease-causing organism. These tests are more sensitive than serology tests and can be used to diagnose diseases at an earlier stage. Biochemical tests measure the levels of certain substances in the blood. These tests can diagnose a wide range of diseases, including diabetes, kidney disease, and liver disease.

The COVID-19 pandemic had a significant impact on the market. Although respiratory droplets are the primary means of COVID-19 virus transmission, research has shown that viral RNA may be discovered in blood samples, supporting blood screening for COVID-19 identification, hence driving the market significantly. 

Blood Screening Market Segmentation

Grand View Research has segmented the global blood screening market based on technology, product, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

Nucleic Acid Amplification Test (NAT)

ELISA

Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)

Next Generation Sequencing

Western Blotting

Product Outlook (Revenue, USD Million, 2018 - 2030)

Reagent

Instrument

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Sweden

Norway

Denmark

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

Saudi Arabia

South Africa

UAE

Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030. 

The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. 

Key Companies & Market Share Insights

Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.

For instance, in March 2023, Abbott received U.S Food and Drug Administration (FDA) clearance for a laboratory traumatic brain injury blood test, the first commercially available lab-based test for the assessment of mild traumatic brain injuries (TBIs), commonly referred to as concussions, which will be made widely available to hospitals across the U.S. This test, which is powered by Abbott’s Alinity i laboratory tool, will enable clinicians to evaluate individuals with mild traumatic brain injuries in a timely manner.

Furthermore, in May 2023, Siemens Healthcare introduced Atellica HEMA 570 and 580 next-generation hematology analyzers, which have user-friendly interfaces and can be connected to multiple analyzers to remove workflow barriers and provide high throughput time.

Key Blood Screening Companies:

Abbott

Danaher Corporation (Beckman Coulter)

Becton Dickinson and Company

Bio-Rad Laboratories, Inc.

Hoffman-La Roche Ltd.

Grifols, S.A.

Ortho-Clinical Diagnostics, Inc.

Siemens Healthcare GmbH

Thermo Fisher Scientific, Inc.

SOFINA s.a (Biomerieux)

Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research. 

[mitalipingale]

The Immunoassay Analyzers Market is expected to reach US$ 142.83 billion by 2031 at a CAGR of 15.45%.